Cargando…

Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer (18)F-FDG PET Radiomics

PET radiomics applied to oncology allow the measurement of intratumoral heterogeneity. This quantification can be affected by image protocols; hence, there is an increased interest in understanding how radiomic expression on PET images is affected by different imaging conditions. To address that int...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolinger, Guilherme D., García, David Vállez, Kramer, Gerbrand Maria, Frings, Virginie, Zwezerijnen, Gerben J.C., Smit, Egbert F., de Langen, Adrianus Johannes, Buvat, Irène, Boellaard, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157719/
https://www.ncbi.nlm.nih.gov/pubmed/34933890
http://dx.doi.org/10.2967/jnumed.121.262660
_version_ 1784718695943110656
author Kolinger, Guilherme D.
García, David Vállez
Kramer, Gerbrand Maria
Frings, Virginie
Zwezerijnen, Gerben J.C.
Smit, Egbert F.
de Langen, Adrianus Johannes
Buvat, Irène
Boellaard, Ronald
author_facet Kolinger, Guilherme D.
García, David Vállez
Kramer, Gerbrand Maria
Frings, Virginie
Zwezerijnen, Gerben J.C.
Smit, Egbert F.
de Langen, Adrianus Johannes
Buvat, Irène
Boellaard, Ronald
author_sort Kolinger, Guilherme D.
collection PubMed
description PET radiomics applied to oncology allow the measurement of intratumoral heterogeneity. This quantification can be affected by image protocols; hence, there is an increased interest in understanding how radiomic expression on PET images is affected by different imaging conditions. To address that interest, this study explored how radiomic features are affected by changes in (18)F-FDG uptake time, image reconstruction, lesion delineation, and radiomic binning settings. Methods: Ten non–small cell lung cancer patients underwent (18)F-FDG PET on 2 consecutive days. On each day, scans were obtained at 60 and 90 min after injection and reconstructed following EARL version 1 and with point-spread-function resolution modeling (PSF-EARL2). Lesions were delineated with an SUV threshold of 4.0, with 40% of SUV(max), and with a contrast-based isocontour. PET image intensity was discretized with both a fixed bin width (FBW) and a fixed bin number before the calculation of the radiomic features. Repeatability of features was measured with the intraclass correlation coefficient, and the change in feature value over time was calculated as a function of its repeatability. Features were then classified into use-case scenarios based on their repeatability and susceptibility to tracer uptake time. Results: With PSF-EARL2 reconstruction, 40% of SUV(max) lesion delineation, and FBW intensity discretization, most features (94%) were repeatable at both uptake times (intraclass correlation coefficient > 0.9), 35% being classified for dual-time-point use cases as being sensitive to changes in uptake time, 39% were classified for cross-sectional studies with an unclear dependency on time, 20% were classified for cross-sectional use while being robust to uptake time changes, and 6% were discarded for poor repeatability. EARL version 1 images had 1 fewer repeatable feature (neighborhood gray-level different matrix coarseness) than PSF-EARL2; the contrast-based delineation had the poorest repeatability of the delineation methods, with 45% of features being discarded; and fixed bin number resulted in lower repeatability than FBW (45% and 6% of features were discarded, respectively). Conclusion: Repeatability was maximized with PSF-EARL2 reconstruction, lesion delineation at 40% of SUV(max), and FBW intensity discretization. On the basis of their susceptibility to uptake time, radiomic features were classified into specific non–small cell lung cancer PET radiomics use cases.
format Online
Article
Text
id pubmed-9157719
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Society of Nuclear Medicine
record_format MEDLINE/PubMed
spelling pubmed-91577192022-12-01 Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer (18)F-FDG PET Radiomics Kolinger, Guilherme D. García, David Vállez Kramer, Gerbrand Maria Frings, Virginie Zwezerijnen, Gerben J.C. Smit, Egbert F. de Langen, Adrianus Johannes Buvat, Irène Boellaard, Ronald J Nucl Med Clinical Investigations PET radiomics applied to oncology allow the measurement of intratumoral heterogeneity. This quantification can be affected by image protocols; hence, there is an increased interest in understanding how radiomic expression on PET images is affected by different imaging conditions. To address that interest, this study explored how radiomic features are affected by changes in (18)F-FDG uptake time, image reconstruction, lesion delineation, and radiomic binning settings. Methods: Ten non–small cell lung cancer patients underwent (18)F-FDG PET on 2 consecutive days. On each day, scans were obtained at 60 and 90 min after injection and reconstructed following EARL version 1 and with point-spread-function resolution modeling (PSF-EARL2). Lesions were delineated with an SUV threshold of 4.0, with 40% of SUV(max), and with a contrast-based isocontour. PET image intensity was discretized with both a fixed bin width (FBW) and a fixed bin number before the calculation of the radiomic features. Repeatability of features was measured with the intraclass correlation coefficient, and the change in feature value over time was calculated as a function of its repeatability. Features were then classified into use-case scenarios based on their repeatability and susceptibility to tracer uptake time. Results: With PSF-EARL2 reconstruction, 40% of SUV(max) lesion delineation, and FBW intensity discretization, most features (94%) were repeatable at both uptake times (intraclass correlation coefficient > 0.9), 35% being classified for dual-time-point use cases as being sensitive to changes in uptake time, 39% were classified for cross-sectional studies with an unclear dependency on time, 20% were classified for cross-sectional use while being robust to uptake time changes, and 6% were discarded for poor repeatability. EARL version 1 images had 1 fewer repeatable feature (neighborhood gray-level different matrix coarseness) than PSF-EARL2; the contrast-based delineation had the poorest repeatability of the delineation methods, with 45% of features being discarded; and fixed bin number resulted in lower repeatability than FBW (45% and 6% of features were discarded, respectively). Conclusion: Repeatability was maximized with PSF-EARL2 reconstruction, lesion delineation at 40% of SUV(max), and FBW intensity discretization. On the basis of their susceptibility to uptake time, radiomic features were classified into specific non–small cell lung cancer PET radiomics use cases. Society of Nuclear Medicine 2022-06 /pmc/articles/PMC9157719/ /pubmed/34933890 http://dx.doi.org/10.2967/jnumed.121.262660 Text en © 2022 by the Society of Nuclear Medicine and Molecular Imaging. https://creativecommons.org/licenses/by/4.0/Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml.
spellingShingle Clinical Investigations
Kolinger, Guilherme D.
García, David Vállez
Kramer, Gerbrand Maria
Frings, Virginie
Zwezerijnen, Gerben J.C.
Smit, Egbert F.
de Langen, Adrianus Johannes
Buvat, Irène
Boellaard, Ronald
Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer (18)F-FDG PET Radiomics
title Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer (18)F-FDG PET Radiomics
title_full Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer (18)F-FDG PET Radiomics
title_fullStr Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer (18)F-FDG PET Radiomics
title_full_unstemmed Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer (18)F-FDG PET Radiomics
title_short Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer (18)F-FDG PET Radiomics
title_sort effects of tracer uptake time in non–small cell lung cancer (18)f-fdg pet radiomics
topic Clinical Investigations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157719/
https://www.ncbi.nlm.nih.gov/pubmed/34933890
http://dx.doi.org/10.2967/jnumed.121.262660
work_keys_str_mv AT kolingerguilhermed effectsoftraceruptaketimeinnonsmallcelllungcancer18ffdgpetradiomics
AT garciadavidvallez effectsoftraceruptaketimeinnonsmallcelllungcancer18ffdgpetradiomics
AT kramergerbrandmaria effectsoftraceruptaketimeinnonsmallcelllungcancer18ffdgpetradiomics
AT fringsvirginie effectsoftraceruptaketimeinnonsmallcelllungcancer18ffdgpetradiomics
AT zwezerijnengerbenjc effectsoftraceruptaketimeinnonsmallcelllungcancer18ffdgpetradiomics
AT smitegbertf effectsoftraceruptaketimeinnonsmallcelllungcancer18ffdgpetradiomics
AT delangenadrianusjohannes effectsoftraceruptaketimeinnonsmallcelllungcancer18ffdgpetradiomics
AT buvatirene effectsoftraceruptaketimeinnonsmallcelllungcancer18ffdgpetradiomics
AT boellaardronald effectsoftraceruptaketimeinnonsmallcelllungcancer18ffdgpetradiomics